This inventor holds 4 USPTO granted patents. Top assignees: The University of Arizona, Research Corporation Tech., Inc.. Active years: 1992-2011.
Company Filing History:
3 out of 1,055 
1 out of 11 Years Active: 1992-2011
Title: John Jacob Marchalonis: Innovator in Immunology
Introduction
John Jacob Marchalonis is a notable inventor based in Tucson, Arizona, recognized for his contributions to immunology. He holds a total of four patents, focusing on innovative methods and compositions aimed at addressing critical health issues, including AIDS and various diseases.
Latest Patents
Among his latest patents is a significant invention titled "Dimerized T-cell receptor fragment, its compositions and use." This patent discloses dimers of a peptide from the T-cell receptor, which are designed to prevent the progression to AIDS in an animal model. The methods outlined in this patent demonstrate how administering dimeric T-cell receptor peptide can restore normal immunological responses following infection. Another important patent is related to the modulation of immune response, which encompasses methods for preventing and treating cardiovascular and allergic diseases, inhibiting tumor growth, and preventing AIDS progression in HIV-infected individuals.
Career Highlights
John Jacob Marchalonis has had a distinguished career, working with esteemed institutions such as the University of Arizona and Research Corporation Technologies, Inc. His work has significantly advanced the understanding and treatment of immune-related conditions.
Collaborations
Marchalonis has collaborated with notable individuals in his field, including Ronald Ross Watson and Marguerite M. Kay. These collaborations have contributed to the development of innovative solutions in immunology.
Conclusion
John Jacob Marchalonis stands out as a pioneering inventor whose work in immunology has the potential to impact the treatment of serious health conditions. His patents reflect a commitment to advancing medical science and improving patient outcomes.